← All Arbutus Biopharma CORP filings

Arbutus Biopharma CORP Form 4 insider transactions

NASDAQ
ABUS
Arbutus Biopharma CORP
Form 4: Arbutus Biopharma Director Acquires Stock Options
James R. Meyers, a director of Arbutus Biopharma Corp, acquired stock options for 67,000 common shares on May 23, 2024.
NASDAQ
ABUS
Arbutus Biopharma CORP
Form 4: Arbutus Biopharma Director Rewolinski Granted Stock Options
Director Melissa Rewolinski of Arbutus Biopharma Corp. was granted stock options for 67,000 common shares on May 23, 2024, fully vested and exercisable immediately.
NASDAQ
ABUS
Arbutus Biopharma CORP
Form 4: Arbutus Biopharma Director Frank Torti Granted Stock Options
Director Frank Torti of Arbutus Biopharma Corp. received stock options for 67,000 common shares on May 23, 2024, fully vested and exercisable immediately.